LUYE PHARMA GROUP LTD. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 2,080 HKD | +0,97% |
|
+3,48% | -4,15% |
Voorlopige winst- en verliesrekening: Luye Pharma Group Ltd.
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 6.358 | 5.540 | 5.200 | 5.982 | 6.143 | 6.397 | 7.064 | 7.927 |
| Variatie | - | -12,87% | -6,13% | 15,03% | 2,7% | 4,13% | 10,44% | 12,21% |
| EBITDA 1 | 2.553 | 1.877 | 906,9 | 1.813 | 2.077 | 2.206 | 2.337 | 2.626 |
| Variatie | - | -26,47% | -51,69% | 99,89% | 14,6% | 6,19% | 5,95% | 12,35% |
| Bedrijfsresultaat (EBIT) 1 | 1.729 | 961,2 | -6,49 | 747,6 | 872,9 | 1.569 | 1.655 | 1.898 |
| Variatie | - | -44,42% | - | - | 16,77% | 79,71% | 5,5% | 14,69% |
| Betaalde rente 1 | -274,6 | -424 | -399,5 | -471,8 | - | -697 | -706 | -744 |
| Resultaat voor belastingen (EBT) 1 | 1.772 | 942,2 | -74,56 | 669,8 | 700,1 | 1.113 | 1.271 | 1.512 |
| Variatie | - | -46,82% | - | - | 4,53% | 59,02% | 14,17% | 18,96% |
| Nettowinst (verlies) 1 | 1.469 | 706,6 | -134,4 | 604,8 | 532,6 | 807 | 915,7 | 1.093 |
| Variatie | - | -51,89% | - | - | -11,94% | 51,52% | 13,46% | 19,36% |
| Datum van publicatie | 26/03/20 | 31/03/21 | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY in Miljoen
Geschatte gegevens
Balansprognose: Luye Pharma Group Ltd.
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | 2.878 | 6.009 | 6.665 | 4.072 | 2.975 | 1.822 | 2.087 | 1.346 |
| Variatie | - | 108,79% | 10,92% | -38,9% | -26,94% | -38,76% | 14,54% | -35,51% |
| Datum van publicatie | 26/03/20 | 31/03/21 | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY in Miljoen
Geschatte gegevens
Verwachte kasstroom: Luye Pharma Group Ltd.
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| CAPEX 1 | 970,4 | 692,8 | 556,2 | 1.163 | 768 | 830 | 908 |
| Variatie | - | -28,6% | -19,72% | 109,16% | - | 8,07% | 9,4% |
| Vrije kasstroom (FCF) 1 | 774,5 | 340,6 | -373,8 | 490,4 | - | - | - |
| Variatie | - | -56,02% | -209,74% | -231,19% | - | - | - |
| Datum van publicatie | 26/03/20 | 31/03/21 | 29/03/22 | 29/03/23 | - | - | - |
1CNY in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: Luye Pharma Group Ltd.
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 40,16% | 33,88% | 17,44% | 30,31% | 33,82% | 34,49% | 33,08% | 33,12% |
| EBIT-marge (%) | 27,2% | 17,35% | -0,12% | 12,5% | 14,21% | 24,52% | 23,43% | 23,94% |
| EBT-marge (%) | 27,87% | 17,01% | -1,43% | 11,2% | 11,4% | 17,4% | 17,99% | 19,07% |
| Nettomarge (%) | 23,1% | 12,76% | -2,58% | 10,11% | 8,67% | 12,62% | 12,96% | 13,79% |
| FCF-marge (%) | 12,18% | 6,15% | -7,19% | 8,2% | - | - | - | - |
| Vrije kasstroom/nettoresultaat (%) | 52,74% | 48,21% | 278,16% | 81,09% | - | - | - | - |
Winstgevendheid | ||||||||
| ROA | 7,97% | 4,56% | 2,03% | - | - | 3% | 3% | 3% |
| ROE | 17,24% | 10,87% | -1,64% | 6,48% | 4,69% | 6,07% | 6,71% | 7,32% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | 1,13x | 3,2x | 7,35x | 2,25x | 1,43x | 0,83x | 0,89x | 0,51x |
| Schuld/vrije kasstroom | 3,72x | 17,64x | -17,83x | 8,3x | - | - | - | - |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 15,26% | 12,51% | 10,7% | 19,45% | - | 12,01% | 11,75% | 11,45% |
| CAPEX / EBITDA (%) | 38,01% | 36,91% | 61,33% | 64,17% | - | 34,81% | 35,51% | 34,58% |
| CAPEX / FCF (%) | 125,29% | 203,39% | -148,78% | 237,21% | - | - | - | - |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 0,5447 | 0,3242 | 0,0529 | 0,4751 | - | - | - | - |
| Variatie | - | -40,48% | -83,68% | 798,13% | - | - | - | - |
| Dividend per aandeel 1 | 0,113 | - | - | - | - | - | - | - |
| Variatie | - | - | - | - | - | - | - | - |
| Nettoactief per aandeel 1 | 2,879 | 2,476 | 2,464 | 2,923 | 3,361 | 3,685 | 3,96 | 4,26 |
| Variatie | - | -14,02% | -0,49% | 18,65% | 14,98% | 9,64% | 7,46% | 7,58% |
| WPA 1 | 0,4584 | 0,2212 | -0,039 | 0,1738 | 0,1429 | 0,219 | 0,2471 | 0,2928 |
| Variatie | - | -51,75% | -117,63% | -545,64% | -17,78% | 53,28% | 12,8% | 18,51% |
| Aantal aandelen (in duizend) | 3.268.965 | 3.248.965 | 3.541.372 | 3.549.671 | 3.761.671 | 3.761.671 | 3.761.671 | 3.761.671 |
| Datum van publicatie | 26/03/20 | 31/03/21 | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY
Geschatte gegevens
| 2024 * | 2025 * | |
|---|---|---|
| K/w-verhouding | 8,8x | 7,8x |
| PBR-ratio | 0,52x | 0,49x |
| EV/omzet | 1,42x | 1,32x |
| Dividendrendement | - | - |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Verkoop
Koop
Gemiddeld advies
Houden
Aantal analisten
4
Laatste slotkoers
1,927CNY
Gemiddelde koersdoel
3,244CNY
Spread / Gemiddelde doel
+68,33%
Kwartaalomzet - Afwijkingspercentage
- Beurs
- Aandelen
- Koers 2186
- Financiën Luye Pharma Group Ltd.
